Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Nutmeg oil is the volatile essential oil obtained by steam distillation from the seeds of *Myristica fragrans* (nutmeg). It is colorless or light yellow and has a characteristic aroma and flavor of nutmeg. The main constituents are terpene hydrocarbons such as sabinene, α-pinene, β-pinene, limonene, and oxygenated compounds like terpinen-4-ol. It also contains phenolic compounds including myristicin, elemicin, safrole, and methyl eugenol[6]. Nutmeg oil is widely used as a natural food flavoring in baked goods and beverages; it also finds applications in cosmetics (e.g., toothpaste) and pharmaceuticals (e.g., cough syrups)[6]. Pharmacologically, nutmeg oil exhibits analgesic properties—studies suggest it can alleviate chronic inflammatory pain by inhibiting cyclooxygenase-2 (COX-2) expression and reducing blood substance P levels[7]. Some components potentiate GABAergic activity in animal models[8]. At high doses or with misuse, toxic effects may occur due to myristicin content; these include CNS excitation or depression, hallucinations, anticholinergic-like symptoms, tachycardia, nausea/vomiting—and rarely death[1][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on nutmeg oil.